Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for ...

St. Jude Medical, Inc. , a global medical device company, today announced 12-month outcome data from the EnligHTN III study, which demonstrated a continuation of safe, rapid and effective treatment with the next-generation EnligHTN™ Renal Denervation System for patients with drug-resistant, uncontrolled hypertension.



from Content Keyword RSS http://ift.tt/1tOhb4C

via IFTTT